Stem Cell & Regenerative Medicine

Stem Cell Embryology

EmbrEmbryonic stem cells (ES cells or ESCs) are pluripotent stem cells derived from the inner cell mass of a blastocyst, a developing embryo. Translational research in stem cell assessments bridges the gap between basic scientific discoveries and clinical applications, focusing on harnessing the potential of stem cells for therapeutic purposes. This interdisciplinary approach involves evaluating the biological properties, differentiation capabilities, and safety of stem cells in laboratory settings before advancing to clinical trials. By integrating insights from molecular biology, genomics, and regenerative medicine, translational research aims to optimize stem cell therapies for various conditions, including neurodegenerative diseases, cancer, and injuries. Ultimately, the goal is to translate promising research findings into effective treatments that can improve patient outcomes, while also addressing the ethical and regulatory challenges associated with stem cell use. Human embryos reach the blastocyst stage, which comprises of 50–150 cells, 4–5 days after fertilisation. The blastocyst is destroyed when the embryoblast, or inner cell mass (ICM), is isolated, presenting ethical questions regarding whether embryos in the pre-implantation stage have the same moral issues as embryos  in the post-implantation stage.